KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Operating Expenses: 2014-2024

Historic Operating Expenses for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $3.8 billion.

  • BeOne Medicines' Operating Expenses rose 10.64% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 12.42%. This contributed to the annual value of $3.8 billion for FY2024, which is 15.15% up from last year.
  • Latest data reveals that BeOne Medicines reported Operating Expenses of $3.8 billion as of FY2024, which was up 15.15% from $3.3 billion recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Operating Expenses registered a high of $3.8 billion during FY2024, and its lowest value of $676.4 million during FY2021.
  • Moreover, its 3-year median value for Operating Expenses was $3.3 billion (2023), whereas its average is $3.3 billion.
  • Its Operating Expenses has fluctuated over the past 5 years, first slumped by 65.60% in 2021, then surged by 331.54% in 2022.
  • BeOne Medicines' Operating Expenses (Yearly) stood at $2.0 billion in 2020, then crashed by 65.60% to $676.4 million in 2021, then spiked by 331.54% to $2.9 billion in 2022, then grew by 12.59% to $3.3 billion in 2023, then grew by 15.15% to $3.8 billion in 2024.